Immix Biopharma Inc
(IMMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,645 | 38 | 0 | 0 | N/A |
| Receivables | 26 | 189 | 0 | 0 | N/A |
| TOTAL | $18,186 | $243 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 6 | 6 | N/A | N/A | N/A |
| Other Non-Current Assets | 0 | 246 | 0 | 0 | 0 |
| TOTAL | $6 | $252 | $N/A | $N/A | $N/A |
| Total Assets | $18,192 | $495 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 4,050 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | 143 | 618 | 0 | 0 | 0 |
| Accrued Expenses | 9 | 436 | 0 | 0 | N/A |
| Other current liabilities | N/A | 1,310 | 0 | 0 | N/A |
| TOTAL | $202 | $6,464 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 227 | 0 | 0 | 0 |
| TOTAL | $N/A | $227 | $N/A | $N/A | $N/A |
| Total Liabilities | $202 | $6,691 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,859 | 7,575 | N/A | N/A | N/A |
| Common Shares | 1 | 0 | 0 | 0 | N/A |
| Retained earnings | -29,756 | -7,000 | 0 | 0 | N/A |
| Other shareholders' equity | 125 | 124 | 0 | 0 | 0 |
| TOTAL | $17,990 | $-6,196 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $18,192 | $495 | $0 | $0 | $0 |